| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHOPHT.124.7.988 |
| P698 | PubMed publication ID | 16832022 |
| P50 | author | Lewis Kuller | Q88077314 |
| P2093 | author name string | Ronald Klein | |
| Mary N Haan | |||
| Barbara E Klein | |||
| Robert B Wallace | |||
| Johanna M Seddon | |||
| David C Musch | |||
| Yingzi Deng | |||
| Leslie G Hyman | |||
| Lynn K Blythe | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macular degeneration | Q27429789 |
| P304 | page(s) | 988-992 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study. | |
| P478 | volume | 124 |
| Q33825549 | A retinal proteomics-based study identifies αA-crystallin as a sex steroid-regulated protein. |
| Q34389315 | Age-related macular degeneration and risk of stroke |
| Q33904895 | Association between reproductive factors and age-related macular degeneration in postmenopausal women: the Korea National Health and Nutrition Examination Survey 2010-2012. |
| Q35846512 | Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative |
| Q36909383 | Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study |
| Q37460938 | Estrogen receptor beta protects against in vivo injury in RPE cells |
| Q35658968 | Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study |
| Q35552553 | Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies |
| Q26828629 | Gaps in menopause knowledge |
| Q34555458 | Genome-wide association and admixture analysis of glaucoma in the Women's Health Initiative |
| Q54990705 | Gonadal Hormones and Retinal Disorders: A Review. |
| Q33844950 | Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms |
| Q36223814 | Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons |
| Q46182713 | Postmenopausal hormone therapy and age-related maculopathy in older women |
| Q30451123 | Postmenopausal hormone therapy: an Endocrine Society scientific statement. |
| Q34193497 | Sunlight exposure, pigmentation, and incident age-related macular degeneration |
| Q33957918 | The prevalence of age-related macular degeneration and associated risk factors |
| Q53608866 | The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors. |
| Q48187463 | Uveoretinal Adverse Effects Presented during Systemic Anticancer Chemotherapy: a 10-Year Single Center Experience. |
| Q35133129 | Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people |
Search more.